NTRA

$378.22

per share, on-chain

What NTRA does

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Industry: Healthcare
Website: natera.com

Ways to own NTRA

There's one version of this stock on Firstshare.

OndoNTRAonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$378.22
Closed until New York opens

Price check

What a slice looks like

$10.00 buys you 0.026 of one NTRA share.

That's 2.6% of one share. Small, but it's yours, and it moves with the real price. One share costs $378.22.